Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Huang

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Cancer|November 20, 2023
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemiaJenny Ruiz, Yimei Li, Lusha Cao, et al.
Leukemia & Lymphoma|January 5, 2016
A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology GroupTamara P Miller, Kelly D Getz, Marko Kavcic, et al.
Pediatric Blood & Cancer|November 20, 2013
Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemiaAlix E Seif, Brian T Fisher, Yimei Li, et al.
Cancer|October 13, 2021
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology GroupEric J Chow, Richard Aplenc, Lynda M Vrooman, et al.
JAMA Oncology|October 23, 2025
National Trends in Dexrazoxane and Cardiovascular Health Care Utilization for Children With Acute Myeloid LeukemiaDaniel J Zheng, Gary Hettinger, Jonathan D Bender, et al.
Haematologica|June 24, 2017
Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupTamara P Miller, Yimei Li, Marko Kavcic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid LeukemiaTamara P Miller, Yimei Li, Marko Kavcic, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2024
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, S Baker, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Cancer|November 20, 2023
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemiaJenny Ruiz, Yimei Li, Lusha Cao, et al.
Leukemia & Lymphoma|January 5, 2016
A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology GroupTamara P Miller, Kelly D Getz, Marko Kavcic, et al.
Pediatric Blood & Cancer|November 20, 2013
Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemiaAlix E Seif, Brian T Fisher, Yimei Li, et al.
Cancer|October 13, 2021
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology GroupEric J Chow, Richard Aplenc, Lynda M Vrooman, et al.
JAMA Oncology|October 23, 2025
National Trends in Dexrazoxane and Cardiovascular Health Care Utilization for Children With Acute Myeloid LeukemiaDaniel J Zheng, Gary Hettinger, Jonathan D Bender, et al.
Haematologica|June 24, 2017
Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupTamara P Miller, Yimei Li, Marko Kavcic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid LeukemiaTamara P Miller, Yimei Li, Marko Kavcic, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2024
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, S Baker, et al.
Pageof 13